Cargando…
FLT4 as a marker for predicting prognostic risk of refractory acute myeloid leukemia
Treating patients with refractory acute myeloid leukemia (AML) remains challenging. Currently there is no effective treatment for refractory AML. Increasing evidence has demonstrated that refractory/relapsed AML is associated with leukemic blasts which can confer resistance to anticancer drugs. We h...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620598/ https://www.ncbi.nlm.nih.gov/pubmed/37317880 http://dx.doi.org/10.3324/haematol.2022.282472 |